Ashwagandha and Blood Pressure: What the Research Shows

Ashwagandha and Blood Pressure is a question that comes up frequently in clinical conversations about adaptogenic herbs. Many people turn to Withania somnifera hoping it will help them manage stress, sleep better, or recover from exercise faster. Because chronic stress and poor sleep are well-established drivers of elevated blood pressure, the logical next question is whether this root extract can directly influence cardiovascular markers. The short answer: human data specifically measuring blood pressure outcomes is limited, but the indirect pathways are well supported and worth understanding.

The Evidence Base

Before we discuss blood pressure specifically, we need to look at what the human trials actually measured. None of the major randomized controlled trials on ashwagandha used blood pressure reduction as a primary endpoint. Instead, they focused on stress, anxiety, sleep, muscle strength, and cognitive function. Blood pressure was sometimes recorded as a secondary safety or exploratory measure, but it was rarely the focus of statistical analysis.

Chandrasekhar et al. (2012) conducted a prospective, randomized, double-blind, placebo-controlled study in adults with chronic stress. Participants received 300 mg of a high-concentration full-spectrum root extract twice daily for 60 days. The primary outcomes were stress-assessment scale scores and serum cortisol levels. While blood pressure was not a reported endpoint, the study demonstrated significant reductions in perceived stress and cortisol, both of which are mechanistically linked to vascular tone. How Ashwagandha Lowers Cortisol: The HPA Axis Mechanism explains this pathway in detail.

Langade et al. (2019) tested ashwagandha root extract in adults with insomnia and anxiety using a randomized, double-blind, placebo-controlled design. The dose was 300 mg twice daily for 10 weeks. Sleep quality and anxiety scores improved significantly. Again, blood pressure was not a primary outcome, but sleep improvement is a recognized non-pharmacological intervention for hypertension management. The mechanism here is indirect: better sleep architecture reduces sympathetic overactivity, which can lower nocturnal and daytime blood pressure.

Wankhede et al. (2015) examined muscle strength and recovery in healthy adults using a randomized, placebo-controlled trial. The ashwagandha group received 300 mg of root extract twice daily for 8 weeks. No cardiovascular endpoints were reported, but the study is relevant because resistance training itself can improve blood pressure, and ashwagandha's role in recovery may support consistent exercise adherence.

Choudhary et al. (2017) studied memory and cognitive functions in adults with mild cognitive impairment. The intervention was 300 mg of root extract twice daily for 8 weeks in a double-blind, placebo-controlled trial. Cognitive outcomes improved, but blood pressure data were not published. Pratte et al. (2014) conducted a systematic review of human trials for ashwagandha in anxiety treatment. They concluded that the evidence was promising but preliminary, and they noted the need for larger, more rigorous trials. No meta-analysis of blood pressure effects was possible because the primary trials did not report it consistently.

Study	Design	Population	Dose & Duration	Primary Outcome	Blood Pressure Data
Chandrasekhar et al. (2012)	RCT, double-blind, placebo-controlled	Adults with chronic stress	300 mg × 2 daily, 60 days	Stress scores, serum cortisol	Not reported
Langade et al. (2019)	RCT, double-blind, placebo-controlled	Adults with insomnia and anxiety	300 mg × 2 daily, 10 weeks	Sleep quality, anxiety scores	Not reported
Wankhede et al. (2015)	RCT, placebo-controlled	Healthy adults	300 mg × 2 daily, 8 weeks	Muscle strength, recovery	Not reported
Choudhary et al. (2017)	RCT, double-blind, placebo-controlled	Adults with mild cognitive impairment	300 mg × 2 daily, 8 weeks	Memory, cognitive function	Not reported
Pratte et al. (2014)	Systematic review	Multiple RCT populations	Variable	Anxiety outcomes	Insufficient data for meta-analysis

The Mechanism

Why would anyone expect ashwagandha to lower blood pressure? The answer lies in its effects on the hypothalamic-pituitary-adrenal (HPA) axis and the broader stress response system. Ashwagandha contains withanolides, steroidal lactones that appear to modulate cortisol signaling and GABA receptor activity. When cortisol is chronically elevated, it upregulates the renin-angiotensin-aldosterone system, increases sodium retention, and enhances vascular sensitivity to catecholamines. All of these effects raise blood pressure.

By reducing cortisol secretion and improving sleep architecture, ashwagandha may indirectly restore normal circadian blood pressure dipping and reduce sympathetic tone. This is not a direct vasodilatory effect like you would see with nitrates or ACE inhibitors. It is a systems-level intervention. The blood pressure benefit, if it exists, is likely a downstream consequence of better stress regulation and sleep quality rather than a pharmacological action on the vasculature itself.

Preclinical research has suggested additional mechanisms, including anti-inflammatory and antioxidant effects that could protect endothelial function. However, human data is limited, and these pathways have not been confirmed in clinical trials using blood pressure as an endpoint. We should be cautious about extrapolating from animal or cell studies to human cardiovascular outcomes.

What the Evidence Does Not Show

It is important to be clear about the gaps. No large-scale RCT has tested ashwagandha against placebo with ambulatory blood pressure monitoring as the primary outcome. The existing trials were not powered for cardiovascular endpoints, and their populations were selected for stress, anxiety, sleep, or cognitive complaints rather than hypertension.

This means we cannot say that ashwagandha lowers blood pressure in the same way we can say that lifestyle modifications like the DASH diet, sodium restriction, or regular aerobic exercise do. Those interventions have dedicated hypertension trials with hard endpoints. Ashwagandha does not. Anyone claiming otherwise is overstating the evidence.

Additionally, the dose and extract type matter. The trials above used a high-concentration full-spectrum root extract or KSM-66, a standardized ashwagandha root extract. Other formulations, including leaf extracts or lower-concentration powders, have not been tested in the same rigorous designs. If you are considering ashwagandha for stress-related blood pressure concerns, the form and standardization level should be part of your decision. Bio:sudo KSM-66 Reishi Restore uses a standardized root extract combined with reishi mushroom, which may offer complementary adaptogenic support, though the combination itself has not been studied in the same trial framework.

Who Benefits Most

The strongest indirect evidence for blood pressure relevance exists in people whose hypertension is stress-predominant or sleep-related. This includes individuals with:

• High perceived stress and elevated cortisol patterns
• Insomnia or non-restorative sleep
• Anxiety disorders with autonomic hyperactivity
• Difficulty adhering to exercise programs due to poor recovery

In these populations, the HPA axis and sleep mechanisms targeted by ashwagandha align with known drivers of blood pressure elevation. Chandrasekhar et al. (2012) showed significant cortisol reduction in stressed adults. Langade et al. (2019) demonstrated sleep improvements in anxious insomniacs. Both effects are relevant to blood pressure regulation, even if the trials did not measure it directly.

People with established, severe hypertension should not rely on ashwagandha as a primary intervention. It is not a replacement for antihypertensive medication, and there are potential interactions to consider. Ashwagandha and Antidepressants: Interactions and Cautions covers some of the pharmacokinetic concerns, though blood pressure medication interactions specifically have not been well studied in humans.

Older adults and those with mild cognitive impairment, as studied by Choudhary et al. (2017), may also benefit from the cognitive and stress-related effects, but cardiovascular outcomes were not assessed. Athletes and active individuals, per Wankhede et al. (2015), may find recovery benefits that support consistent training, which indirectly benefits blood pressure over time.

Practical Considerations and Safety

Dosing in the positive trials was consistently 300 mg of standardized root extract taken twice daily, typically for 8–10 weeks. This appears to be the evidence-based starting point. Lower doses or sporadic use have not been rigorously tested. The full-spectrum and KSM-66 extracts used in these studies are root-only formulations, not leaf blends, which matters for standardization.

Safety data from the RCTs suggest that ashwagandha is well tolerated at these doses, with mild gastrointestinal upset being the most common complaint. However, Ashwagandha Side Effects: What the Clinical Evidence Shows provides a more complete picture, including considerations for thyroid function, pregnancy, and autoimmune conditions. People on blood pressure medications should discuss use with a clinician, as additive effects on stress hormones could theoretically interact with drug metabolism or vascular response, though direct evidence is lacking.

Timing may also matter. Because ashwagandha can be mildly sedating for some people, evening dosing may support sleep architecture, while morning dosing may be preferable for daytime stress management. Individual response varies, and no trial has directly compared timing strategies.

Practical Takeaways

• Human trials on ashwagandha have not used blood pressure as a primary endpoint, so direct claims about lowering blood pressure are unsupported.
• The herb's effects on cortisol, stress, and sleep create plausible indirect pathways for blood pressure benefit, especially in stress-predominant hypertension.
• Evidence-based dosing is 300 mg of standardized root extract twice daily for 8–10 weeks, based on the RCTs by Chandrasekhar et al. (2012) and Langade et al. (2019).
• Choose root extracts with verified standardization, such as KSM-66 or high-concentration full-spectrum extracts, rather than unstandardized powders or leaf-based products.
• Do not replace prescribed antihypertensive medication with ashwagandha without medical supervision.
• If your blood pressure is primarily driven by stress, poor sleep, or anxiety, ashwagandha may be a reasonable adjunct to lifestyle and medical management, but expectations should be modest.

Bottom Line

Ashwagandha and Blood Pressure is not a relationship that has been directly tested in large human trials, and we should be honest about that limitation. The existing evidence supports its use for stress reduction, anxiety, and sleep improvement, mechanisms that are themselves linked to better cardiovascular regulation. For people with stress-predominant blood pressure patterns, a standardized root extract at 300 mg twice daily is a defensible, evidence-informed choice, but it should complement, not replace, proven interventions. Bio:sudo KSM-66 Reishi Restore offers a standardized root extract formulation for those who want to explore this pathway with a product aligned to the trial evidence.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]

---

---